Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients.

[1]  G. Davis,et al.  Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. , 1995, The Journal of infectious diseases.

[2]  A. Keller,et al.  Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey , 1994, Journal of clinical microbiology.

[3]  W. Quint,et al.  Sequence analysis of the 5' untranslated region in isolates of at least four genotypes of hepatitis C virus in The Netherlands , 1994, Journal of clinical microbiology.

[4]  P. Simmonds,et al.  Hepatitis C serotype and response to interferon therapy. , 1994, The New England journal of medicine.

[5]  S Sherlock,et al.  Hepatitis C virus genotypes: An investigation of type‐specific differences in geographic origin and disease , 1994, Hepatology.

[6]  T. Jomori,et al.  Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon‐β , 1993, Hepatology.

[7]  K. Chayama,et al.  Factors useful in predicting the response to interferon therapy in chronic hepatitis C , 1993, Journal of gastroenterology and hepatology.

[8]  G. Davis,et al.  Significance of serum hepatitis C virus RNA levels in chronic hepatitis C , 1993, The Lancet.

[9]  P. Simmonds,et al.  Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3 , 1993, Journal of clinical microbiology.

[10]  L. Stuyver,et al.  Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. , 1993, The Journal of general virology.

[11]  K. Chayama,et al.  Genotypic subtyping of hepatitis C virus , 1993, Journal of gastroenterology and hepatology.

[12]  N. Hayashi,et al.  Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. , 1993, Gastroenterology.

[13]  P. Simmonds,et al.  Detection of three types of hepatitis C virus in blood donors: investigation of type‐specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities , 1993, Transfusion.

[14]  Motohiro Shibata,et al.  Detection of hepatitis C virus by polymerase chain reaction and response to interferon‐α therapy: Relationship to genotypes of hepatitis C virus , 1992, Hepatology.

[15]  Koichi Kanai,et al.  HCV genotypes in chronic hepatitis C and response to interferon , 1992, The Lancet.

[16]  C. Lee,et al.  Identification of hepatitis C viruses with a nonconserved sequence of the 5' untranslated region , 1992, Journal of clinical microbiology.

[17]  H. Okamoto,et al.  Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. , 1992, The Journal of general virology.

[18]  N. Enomoto,et al.  Clinical backgrounds of the patients having different types of hepatitis C virus genomes. , 1992, Journal of hepatology.

[19]  N. Enomoto,et al.  There are two major types of hepatitis C virus in Japan. , 1990, Biochemical and biophysical research communications.

[20]  Eugene R. Schiff,et al.  Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa , 1989 .

[21]  S. Banks,et al.  Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. , 1989, The New England journal of medicine.